Viking Therapeutics Stock Analysis

Viking Stock Analysis Notes

About 72.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 0.91. Viking Therapeutics had not issued any dividends in recent years. Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company was incorporated in 2012 and is headquartered in San Diego, California. Viking Thera operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. For more information please call Brian Lian at 858 704 4660 or visit https://www.vikingtherapeutics.com.

Viking Therapeutics Investment Alerts

Viking Therapeutics Upcoming and Recent Events

Viking Largest EPS Surprises

View All Earnings Estimates

Viking Therapeutics Thematic Classifications

Viking Stock Institutional Investors

Note, although Viking Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Viking Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.27 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Viking Therapeutics's market, we take the total number of its shares issued and multiply it by Viking Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Viking Profitablity

Management Efficiency

Viking Therapeutics has return on total asset (ROA) of (0.1278) % which means that it has lost $0.1278 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1755) %, meaning that it created substantial loss on money invested by shareholders. Viking Therapeutics' management efficiency ratios could be used to measure how well Viking Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.24 in 2024. Return On Capital Employed is likely to drop to -0.3 in 2024. At this time, Viking Therapeutics' Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 385.6 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 755.8 K in 2024.

Technical Drivers

As of the 25th of April, Viking Therapeutics has the Semi Deviation of 4.92, coefficient of variation of 666.48, and Risk Adjusted Performance of 0.1033. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viking Therapeutics, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Viking Therapeutics, which can be compared to its competition. Please validate Viking Therapeutics value at risk, and the relationship between the jensen alpha and semi variance to decide if Viking Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 65.07 per share. Given that Viking Therapeutics has jensen alpha of 2.21, we advise you to double-check Viking Therapeutics's current market performance to make sure the company can sustain itself at a future point.

Viking Therapeutics Price Movement Analysis

Viking Therapeutics Insider Trading Activities

Viking Therapeutics Predictive Daily Indicators

Viking Therapeutics Corporate Filings

Viking Therapeutics Forecast Models

Viking Therapeutics' time-series forecasting models are one of many Viking Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Viking Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Viking Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Viking shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Viking Therapeutics. By using and applying Viking Stock analysis, traders can create a robust methodology for identifying Viking entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Viking analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Viking analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Viking Therapeutics stock analysis indicators help investors evaluate how Viking Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Viking Therapeutics shares will generate the highest return on investment. By understating and applying Viking Therapeutics stock analysis, traders can identify Viking Therapeutics position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viking Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.

Is Viking Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viking Therapeutics. If investors know Viking will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viking Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Viking Therapeutics is measured differently than its book value, which is the value of Viking that is recorded on the company's balance sheet. Investors also form their own opinion of Viking Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Viking Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viking Therapeutics' market value can be influenced by many factors that don't directly affect Viking Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Viking Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viking Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viking Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.